Weil Company, Inc. Vbi Vaccines Inc Transaction History

Weil Company, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $82,866 - $110,093	-29,595 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$2.61 - $4.17 $70,704 - $112,965	-27,090 Reduced 47.79%	29,595 $99,000
Q1 2021 May 12, 2021	SELL	$2.91 - $4.32 $95,238 - $141,384	-32,728 Reduced 36.6%	56,685 $176,000
Q4 2020 Feb 10, 2021	BUY	$2.15 - $3.5 $32,250 - $52,500	15,000 Added 20.16%	89,413 $246,000
Q3 2020 Nov 12, 2020	SELL	$2.77 - $6.17 $4,235 - $9,433	-1,529 Reduced 2.01%	74,413 $213,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $3.13 $13,050 - $46,950	15,000 Added 24.61%	75,942 $235,000
Q1 2020 May 15, 2020	SELL	$0.73 - $1.91 $21,900 - $57,300	-30,000 Reduced 32.99%	60,942 $58,000
Q4 2019 Feb 13, 2020	SELL	$0.48 - $1.38 $7,647 - $21,987	-15,933 Reduced 14.91%	90,942 $125,000
Q3 2019 Nov 13, 2019	BUY	$0.47 - $1.05 $16,450 - $36,750	35,000 Added 48.7%	106,875 $50,000
Q2 2019 Aug 12, 2019	BUY	$0.65 - $2.12 $32,500 - $106,000	50,000 Added 228.57%	71,875 $84,000
Q1 2019 May 13, 2019	BUY	$1.54 - $2.01 $33,687 - $43,968	21,875 New	21,875 $41,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Weil Company, Inc. with notifications on news.